Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Will Berwick Transform CMS Into Center For Health Quality?

Executive Summary

CMS Administrator-nominee Donald Berwick now has the opportunity to test out his quality improvement ideas on a national stage

You may also be interested in...



HHS "Partnership For Patients" Plan Includes Goal Of Halving Preventable Drug Adverse Events In Hospitals

New initiative's targets also include reducing preventable hospital-acquired conditions 40% by the end of 2013.

White House Makes Berwick CMS Chief Via Recess Appointment

White House says "many Republicans in Congress have made it clear in recent weeks that they were going to stall the nomination as long as they could, solely to score political points."

HHS ASPE Nominee Glied Joins Queue For Senate Floor Vote

HHS Assistant Secretary for Planning and Evaluation nominee Sherry Glied moved closer to Senate approval May 27 as the Finance Committee approved her nomination

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel